Introduction
Cellular accumulation of nutrients involves a wide variety of carriers including the peptide transporters 1 (PEPT1) and 2 (PEPT2), which accept di-and tripeptides [1] [2] [3] as well as peptide-like drugs [1, 2] . PEPT1 is a high-capacity, low-affinity peptide transporter and PEPT2 a low-capacity, high-affinity peptide transporter [4] . PEPT1 and PEPT2 are both expressed in the renal proximal tubule [4, 5] . PEPT1 is mainly expressed in early parts of the proximal tubule, whereas PEPT2 prevails in latter parts of the proximal tubule [4] . PEPT1 is the major peptide transporter expressed in intestine [4] . PEPT2 is expressed by neurons and glial cells of cerebral cortex, olfactory bulb, basal ganglia, cerebellum and hindbrain as well as epithelial cells of the choroid plexus and ependymal cells [4] . PEPT1 is further expressed in the pancreas, bile duct and liver, and PEPT2 in the lung, mammary gland and spleen [4] . The peptide transporters are regulated by several hormones including leptin [6] and growth hormone [7] .
Kinases hitherto identified in the regulation of peptide transporters include phosphoinositide (PI) 3 kinase [8] , phosphoinositide dependent kinase PDK1 [8] , serum & glucocorticoid inducible kinase SGK1 [9] and AMP activated kinase [10] . Kinases involved in the regulation of epithelial transport include SPAK (STE20-related proline/alanine-rich kinase) [11] [12] [13] . SPAK is regulated by with-no-K(Lys) (WNK) kinases [11, [14] [15] [16] [17] , which are powerful regulators of renal tubular ion transport and blood pressure [18] [19] [20] [21] [22] . Specifically, SPAK and the related oxidative stress-responsive kinase 1 (OSR1) kinase upregulate the Na + ,Cl -(NCC) and the Na
-(NKCC2) cotransporters [14, 15, 18, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Mutations of genes encoding WNK kinases underly Gordon's syndrome, a monogenic disease leading to hypertension and hyperkalaemia [16, 17, 34, 35] . By regulation of ion transport, SPAK contributes to cell volume regulation [24, 36] . Most recent observations pointed to a role of OSR1 and/or SPAK in the regulation of Na + coupled phosphate transport [37, 38] , and Na + /H + exchanger [39] , pointing to a broader role of those kinases in the regulation of epithelial transport. To the best of our knowledge, nothing is hitherto known about a role of SPAK in the regulation of peptide transporters.
The present study thus explored whether SPAK influences the function of PEPT1 and/ or PEPT2. To this end, cRNA encoding the peptide transporters were injected into Xenopus laevis oocytes with or without cRNA encoding SPAK and peptide transport quantified by determination of peptide induced current. To define the in vivo significance of SPAK sensitive peptide transport regulation, peptide induced current was determined in Ussing chamber experiments of intestinal segments isolated either from gene targeted mice expressing SPAK resistant to WNK-dependent activation (spak tg/tg ) mice or from corresponding wild-type (spak +/+ ) mice.
Materials and Methods

Constructs
Constructs encoding rabbit PEPT1, rabbit PEPT2 and haemagglutinin labelled PEPT2-HA [40] , wildtype SPAK, WNK1 insensitive inactive T233A SPAK, constitutively active T233E SPAK, and catalytically inactive D212A SPAK [14] , were used for generation of cRNA as described previously [41] .
Voltage clamp in Xenopus laevis oocytes
Xenopus laevis oocytes were prepared as previously described [42, 43] . Where not indicated otherwise, 10 ng PEPT1 or 20 ng PEPT2 cRNA on the first day and 10 ng of wild-type SPAK, SPAK cRNA were injected on the same day after preparation of the oocytes [44] . The oocytes were maintained at 17°C in ND96 solution containing (in mM): 88.5 NaCl, 2 KCl, 1 MgC1 2 , 1.8 CaC1 2 , 2.5 NaOH, 5 HEPES (pH 7.4) and 5 sodium pyruvate (C 3 H 3 NaO 3 ). pH7.4. Gentamycin (100 mg/l), Tetracycline (50 mg/l), Warsi/Dong/Elvira/Salker/Shumilina/Hosseinzadeh/Lang: SPAK Sensitive PEPT1/2 Activity Ciprofloxacin (1.6 mg/l), and Theophiline (90 mg/l) were added. Where indicated, Brefeldin A (5 µM) was added to the respective solutions. The experiments were performed at room temperature 3 to 4 days after injection. Two-electrode voltage-clamp recordings were performed at a holding potential of -70 mV. The data were filtered at 10 Hz and recorded with a Digidata A/D-D/A(1322A Axon Instruments) converter and Clampex 9.2 software for data acquisition and analysis (Axon Instruments). The control superfusate (ND96) contained (in mM): 93.5 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2, 2.5 NaOH and 5 HEPES (pH 7.4). Glycine-glycine was added to the solutions at a concentration of 2 mM, unless otherwise stated. The flow rate of the superfusion was approx. 20 ml/min, and a complete exchange of the bath solution was reached within about 10 s [45, 46] .
Chemiluminescence
For detection of PEPT2-HA cell surface expression, the oocytes were first incubated with primary mouse monoclonal anti-HA antibody conjugated to horseradish peroxidase (1:1000, Miltenyi Biotec Inc, CA, USA). Individual oocytes were placed in 96 well plates with 20 µl of SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce) and chemiluminescence of single oocytes was quantified in a luminometer (Walter Wallac 2 plate reader, Perkin Elmer) by integrating the signal over a period of 1 sec [47] . Results display normalized relative light units. Integrity of the measured oocytes was assessed by visual control after the measurement to avoid unspecific light signals from the cytosol [48] .
Ussing chamber experiments
All animal experiments were conducted according to the German law for the welfare of animals and according to the guidelines of the American Physiological Society and were approved by local authorities. Experiments have been performed using intestinal segments from 7-8 week old female gene targeted mice expressing SPAK resistant to WNK-dependent activation (spak tg/tg ) and in mice expressing wild-type SPAK (spak
) [38] . The mice were fed a control diet (1314, Altromin, Heidenau, Germany) and had free access to tap drinking water.
For analysis of electrogenic intestinal peptide transport, jejunal segments were mounted into a custom made mini-Ussing chamber with an opening of 0.00769 cm 2 . Under control conditions, the serosal and luminal perfusate contained (in mM): 115 NaCl, 2 KCl, 1 MgCl 2 , 1.25 CaCl 2 , 0.4 KH 2 PO 4 , 1.6 K 2 HPO 4 , 5 Sodium Pyruvate (C 3 H 3 NaO 3 ), 25 NaHCO 3 , 5 mannitol (pH 7.4, NaOH). Where indicated, the dipeptide glycine-glycine (5 mM) was added to the luminal perfusate at the expense of mannitol (5 mM) (all substances were from Sigma, Schnelldorf, Germany, or from Roth, Karlsruhe, Germany).
In all Ussing chamber experiments the transepithelial potential difference (Vt) was determined continuously and the transepithelial resistance (Rt) was estimated from the voltage deflections (ΔVt) elicited by imposing test currents (I t ). The resulting Rt was calculated according to Ohm's law [40] .
Statistical analysis
Data are provided as means ± SEM, n represents the number of oocytes or intestinal segments investigated. All voltage clamp experiments were repeated with at least 3 batches of oocytes; in all repetitions qualitatively similar data were obtained. Data were tested for significance using ANOVA (Tukey test or Kruskal-Wallis test) or t-test, as appropriate. Results with p < 0.05 were considered statistically significant.
Results
The present study explored whether SPAK participates in the regulation of peptide transport. To this end, cRNA encoding PEPT1 was injected into Xenopus laevis oocytes with or without additional injection of cRNA encoding wild-type, constitutively active or inactive SPAK. Peptide transport was estimated from the current generated by addition of the dipeptide glycine-glycine to the bath solution (I gly-gly ).
No appreciable I gly-gly was observed in water injected Xenopus laevis oocytes (Fig. 1Aa,B) . Accordingly, Xenopus laevis oocytes did not express measureable endogenous electrogenic glycine-glycine transport. As illustrated in Fig. 1 , addition of glycine-glycine (2mM) to Xeno-Warsi/Dong/Elvira/Salker/Shumilina/Hosseinzadeh/Lang: SPAK Sensitive PEPT1/2 Activity pus laevis oocytes injected with cRNA encoding PEPT1 was followed by appearance of I gly-gly . Additional expression of wild-type SPAK resulted in a significant decrease of I gly-gly in PEPT1 expressing Xenopus laevis oocytes (Fig. 1) .
In order to determine maximal transport rate and affinity of PEPT1, the oocytes were exposed to glycine-glycine concentrations ranging from 0.01 to 5 mM. As illustrated in Fig. 2 , the increase of peptide concentration was followed by an increase of I gly-gly in both, Xenopus laevis oocytes expressing PEPT1 alone and Xenopus laevis oocytes expressing PEPT1 and SPAK. The increase of I gly-gly was, however, larger in Xenopus laevis oocytes expressing PEPT1 alone than in Xenopus laevis oocytes expressing PEPT1 with SPAK. Calculation of maximal currents utilizing the Michaelis Menten equation yielded values, which were significantly (p<0.01) lower in Xenopus laevis oocytes expressing PEPT1 together with SPAK (22.4 ± 1.6 nA, n = 11-12), than in Xenopus laevis oocytes expressing PEPT1 alone (31.2 ± 2.4 nA, n = 11-12). Calculation of glycine-glycine concentrations required for halfmaximal current (K M ) did not yield significantly different values in Xenopus laevis oocytes expressing PEPT1 together with SPAK (946 ± 227 mM, n = 11-12) and in Xenopus laevis oocytes expressing PEPT1 alone (795 ± 82 mM, n = 11-12) (Fig. 2) .
The effect of wild-type SPAK was mimicked by constitutively active In order to test whether SPAK similarly regulates PEPT2, cRNA encoding PEPT2 was injected into Xenopus laevis oocytes with or without additional injection of cRNA encoding wild-type SPAK. As shown in Fig. 4 , I gly-gly was lower in oocytes expressing PEPT2 with wild-type SPAK than oocyte expressing PEPT2 alone (Fig.4) . The down-regulation of I gly-gly in PEPT1 or PEPT2-expressing Xenopus laevis oocytes following coexpression of SPAK could have resulted from a decline of protein abundance in the cell membrane. Thus, chemiluminescence was employed to quantify the carrier protein abundance in the cell membrane. As illustrated in Fig. 5 , coexpression of wild-type SPAK resulted in a significant decrease of the PEPT2 protein abundance in the cell membrane of PEPT2 expressing Xenopus laevis oocytes.
Additional experiments were performed to determine the stability of I gly-gly following disruption of new carrier protein insertion into the cell membrane by Brefeldin A (5 µM). As illustrated in Fig. 6 , following addition of Brefeldin A, I gly-gly did not decline faster in Xenopus laevis oocytes expressing PEPT1 together with SPAK than in Xenopus laevis oocytes expressing PEPT1 alone. Thus, SPAK decreased I gly-gly by a mechanism other than accelerating carrier clearance from the cell membrane.
In order to define the in vivo significance of SPAK sensitive regulation of peptide transporters, peptide induced current was determined in Ussing chamber experiments of intestinal segments isolated from 16-week-old female gene targeted mice carrying WNK insensitive SPAK (spak tg/ tg ) or corresponding wild-type mice (spak +/+ ). As illustrated in Fig. 7 , addition of glycineglycine (5 mM) to the luminal perfusate generated a transepithelial current (I gly-gly ), which was significantly higher in intestinal epithelium from spak tg/tg mice than from spak +/+ mice. Warsi/Dong/Elvira/Salker/Shumilina/Hosseinzadeh/Lang: SPAK Sensitive PEPT1/2 Activity
Discussion
The present study reveals that SPAK (STE20-related proline/alanine-rich kinase) downregulates the peptide transporters PEPT1 and PEPT2. Coexpression of SPAK, of constitutively active T233E SPAK, but not of catalytically inactive D212A SPAK or WNK1 insensitive inactive T233A SPAK was followed by a decrease of electrogenic dipeptide transport in PEPT1 expressing Xenopus laevis oocytes. As the catalytically inactive T233A SPAK was not effective, the effect apparently requires kinase activity. The effect on PEPT2 resulted at least in part from a decrease of PEPT2 protein abundance in the cell membrane. The experiments with Brefeldin A suggest that SPAK was not effective by enhancing PEPT1 carrier retrieval from the cell membrane and are compatible with the assumption that SPAK delayed carrier insertion into the cell membrane. The down-regulating effect of SPAK on the peptide transporters is in seeming contrast to the upregulation of the Na + ,Cl -(NCC) and the Na
-(NKCC2) cotransporters [14, 15, 18, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Presumably, the mechanisms involved in the regulation of the peptide transporters are distinct from those regulating NCC and NKCC. SPAK influences NCC and NKCC at least in part by direct phosphorylation of the carrier protein [33] . The mechanism underlying SPAK sensitivity of the peptide transporters remains to be identified. The in vivo significance of the observations in Xenopus laevis oocytes is underscored by the observation that the peptide induced current was higher in spak tg/tg than in spak +/+ mice. The possibility should be kept in mind, though, that SPAK deficiency may indirectly modify intestinal peptide transport.
The peptide transporters significantly contribute to intestinal nutrient uptake [2, 49] , and the majority of dietary nitrogen is taken up by PEPT1 [50] . Thus, SPAK sensitivity of PEPT1 is expected to impact on intestinal nutrient transport.
At least in theory, the impact of SPAK on intestinal peptide transport may be particularly relevant for altered intestinal transport in intestinal inflammation, which involves altered intestinal SPAK [51] and PEPT1 [3] activity. In the absence of inflammation, PEPT1 expression is restricted to small intestine [3] . PEPT1 is, however, highly expressed in colon following inflammatory bowel disease (IBD) [3] .
SPAK interacts with several kinases, such as p38 kinase, Jun activated kinase (JNK), protein kinase C theta (PKCtheta), with no K kinase (WNK) and myosin light chain kinase (MLCK), kinases participating in the signalling of cell differentiation, cell transformation, cell proliferation, and cytoskeleton architecture [51] . Whether or not SPAK modifies cellular peptide uptake during differentiation, cell transformation and/or cell proliferation, remains to be shown. Whether sensitivity of SPAK activity to cell volume [24, 36] impacts on the regulation of peptide transporters, similarly remains to be shown.
Peptide transporters mediate the transport of several drugs including beta-lactam antibiotics, angiotensin-converting enzyme inhibitors, antiviral drugs, and anti-cancer agents [2, 49, [52] [53] [54] [55] . Peptide transporters are thus not only important for cellular nutrient uptake but as well for cellular drug uptake [1, 10, 56, 57] . The transporters are, for instance, expressed in pancreatic cancer cells [58] and prostate cancer cells [59] and the carriers have been considered potential targets for tumor therapy [59] . Whether or not drug uptake into tumor cells is sensitive to SPAK, remains to be shown.
Conclusion
The present observations reveal a powerful effect of SPAK on the activity of the peptide transporters, PEPT1 and PEPT2. As shown for PEPT2, the kinase is effective by decreasing carrier protein abundance in the cell membrane. SPAK sensitive regulation of peptide transporters may be relevant for cellular peptide and xenobiotic uptake in intestine and presumably other polarized or non-polarized cell types.
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